Glutathione Market Size

Glutathione Market size was valued at USD 390 million in 2024 and is projected to reach USD 871 million by the end of 2037, rising at a CAGR of 7.9% during the forecast period, 2025 to 2037. In 2025, the industry size of glutathione is estimated at USD 420 million

The glutathione market serves a substantial end user base that suffers from chronic conditions linked to oxidative stress, including liver diseases, neurodegenerative ailments, and diabetes. Over a billion individuals are affected by chronic disorders, where more than 400 million people diagnosed with diabetes. 134 million in the U.S. suffer from chronic conditions, thus driving glutathione administration in clinical settings. The glutathione supply chain is dependent on cysteine and glutamic acid sourcing. China is the top supplier of amino acid precursors.

Additionally, the production process consists of fermentation and purification in GMP facilities. This assembly line is primarily concentrated in Asia Pacific and holds a staggering 72% of the world's capacity. The glutathione market prominence can be gauged by the overall trade scenario. In 2023, the U.S. imported 16,510 metric tons of amino acids, of which over 60% was utilized for nutraceuticals and pharmaceuticals. The producer price index (PPI) for pharmaceutical components surged by 2.9% between 2023 and 2024, showcasing rising API costs. On the other hand, the consumer price index (CPI) for prescription medicines spiked by 3.5%, emphasizing the higher costs for glutathione-based therapies.

Glutamic Acid, Salts Global Trade, 2023

Source: OEC